With 41 novel drug approvals under the regulators’ belts last year, 2014 represented an 18-year high for the Food and Drug Administration – including a record number of okayed meds for orphan diseases, the Associated Press says:
FDA drug approvals are considered a barometer of industry innovation and the federal government’s efficiency in reviewing new therapies. Last year’s total was the most since the all-time high of 53 drugs approved in 1996.